🇺🇸 FDA
Patent

US 8357697

Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto

granted A61PA61P25/00A61P25/14

Quick answer

US patent 8357697 (Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P25/00, A61P25/14, A61P43/00